HeartSciences (HSCS) Proxy filing summary

Executive summary

• Annual Meeting scheduled for November 7, 2024, to address key corporate matters for the fiscal year ended April 30, 2024.

• Meeting will be held virtually, allowing shareholders to participate and vote online.

• Record date for voting is September 16, 2024; both common and Series C Preferred shareholders are eligible.

• Proxy materials are available online to reduce costs and environmental impact.

Voting matters and shareholder proposals

• Shareholders will vote on ratifying Haskell & White LLP as independent auditor for fiscal 2025.

• Approval sought for potential adjournment of the meeting to solicit additional proxies if needed.

• Board recommends voting FOR both proposals.

• Shareholder proposals for the 2025 meeting must be submitted by April 30, 2025, to be included in proxy materials.

Board of directors and corporate governance

• Board consists of five directors, three of whom are independent.

• Annual election of certain directors and regular board self-assessments.

• Nominating Committee emphasizes diversity in skills, experience, and background.

• Chairman and CEO roles are combined due to company size and stage.